Risk of progression after nephrectomy for non-metastatic clear cell renal cell carcinoma: Comparison of the predictive ability of validated risk models

被引：0
|
作者：
Palumbo, C. [1 ]
Perri, D. [1 ]
Zacchero, M. [1 ]
Bondonno, G. [1 ]
Di Martino, J. [1 ]
D'Agate, D. [1 ]
Volpe, A. [1 ]
机构：
[1] Azienda Osped Univ Maggiore Carita, Dept Urol, Novara, Italy
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0061
引用
收藏
页码：S93 / S94
页数：2
相关论文
共 50 条
  • [31] Defining individual recurrence risk following surgery for high risk non-metastatic renal cell carcinoma.
    Abel, Edwin J.
    Raman, Jay D.
    Shapiro, Daniel D.
    Chan, Wilson
    Allen, Glenn O.
    Patil, Dattatraya
    Master, Viraj A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [32] Lymph node dissection during radical nephrectomy for clinical node negative, non-metastatic, clear cell renal cell carcinoma: Indications and extent
    Dwivedi, Amod Kumar
    Nagathan, Deepak S.
    Goel, Apul
    INDIAN JOURNAL OF UROLOGY, 2011, 27 (02) : 297 - 298
  • [33] Recurrence risk groups after nephrectomy for renal cell carcinoma
    Polanco Pujol, L.
    Herranz Amo, F.
    Cano Velasco, J.
    Subira Rios, D.
    Moralejo Garate, M.
    Hernandez Cavieres, J.
    Barbas Bernardos, G.
    Bueno Chomon, G.
    Rodriguez Fernandez, E.
    Hernandez Fernandez, C.
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (02): : 111 - 118
  • [34] Prognostic impact of peripheral blood counts in patients with non-metastatic clear cell renal cell carcinoma
    Hammond, William Adam
    Lewis, Daniel
    Hassan, Lauren
    Serie, Daniel
    Thai Huu Ho
    Eckel-Passow, Jeanette
    Leibovich, Bradley C.
    Thompson, Robert Houston
    Cheville, John C.
    Parker, Alexander S.
    Joseph, Richard Wayne
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease
    Wagener, Nina
    Edelmann, Dominic
    Benner, Axel
    Zigeuner, Richard
    Borgmann, Hendrik
    Wolff, Ingmar
    Krabbe, Laura M.
    Musquera, Mireia
    Dell'Oglio, Paolo
    Capitanio, Umberto
    Klatte, Tobias
    Cindolo, Luca
    May, Matthias
    Brookman-May, Sabine D.
    PLOS ONE, 2017, 12 (09):
  • [36] SHOULD PATIENTS WITH METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA UNDERGO CYTOREDUCTIVE NEPHRECTOMY?
    Keskin, Sarp
    Petros, Firas
    Yu, Kai-jie
    Aboshady, Yara
    Borregales, Leonardo
    Kenney, Patrick
    Matin, Surena
    Karam, Jose
    Wood, Christopher
    JOURNAL OF UROLOGY, 2017, 197 (04): : E65 - E66
  • [37] MICRORNAS PREDICTING METASTATIC PROGRESSION OF CLEAR CELL RENAL CELL CARCINOMA
    Kowalik, Casey
    Lebeis, Christopher W.
    Waldorf, Benjamin
    Sullivan, Travis
    Libertino, John A.
    Rieger-Christ, Kimberly
    JOURNAL OF UROLOGY, 2014, 191 (04): : E246 - E246
  • [38] Comparison of Risk Factors for the Development of Proteinuria After Radical Nephrectomy for Renal Cell Carcinoma
    Lee, Chung Un
    Choi, Don Kyoung
    Chung, Jae Hoon
    Song, Wan
    Kang, Minyong
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Jeon, Hwang Gyun
    RESEARCH AND REPORTS IN UROLOGY, 2021, 13 : 407 - 414
  • [39] RISK CLASSIFICATION TO PREDICT SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Shinohara, Nobuo
    Abe, Takashige
    Maruyama, Satoru
    Sazawa, Ataru
    Nonomura, Katsuya
    JOURNAL OF UROLOGY, 2012, 187 (04): : E723 - E723
  • [40] Predictive nomogram for ischemic stroke risk in clear cell renal cell carcinoma patients
    Wen, Jie
    Rong, Yi
    Kang, Yinbo
    Lv, Dingyang
    Cui, Fan
    Zhou, Huiyu
    Jia, Mohan
    Wang, Qiwei
    Shuang, Weibing
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345